Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-05

Clinical Trial Update: Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder [Phase 1, Phase 2]

View source ↗

Summary

An update on the effectiveness of the ADHD@Home personalized neurofeedback training device for Attention-Deficit/Hyperactivity Disorder across Phase 1 and Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADHD@Home Neurofeedback Training Device

Snippet

Sponsor: Mensia Technologies SA | Conditions: Attention Deficit-Hyperactivity Disorder | Phase 1, Phase 2 | Status: UNKNOWN